Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
Switch Symbol:
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$179.28M
↑ 116% above average
Average (9y)
$83.18M
Historical baseline
Range
High:$179.28M
Low:$4.48M
CAGR
+22.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $179.28M | +53.4% |
| 2023 | $116.88M | -2.8% |
| 2022 | $120.24M | -19.4% |
| 2021 | $149.24M | +37.4% |
| 2020 | $108.62M | +83.2% |
| 2019 | $59.29M | +33.2% |
| 2018 | $44.51M | +892.6% |
| 2017 | $4.48M | -78.0% |
| 2016 | $20.38M | -29.5% |
| 2015 | $28.89M | - |